{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:40:59Z","timestamp":1792784459349,"version":"4.5.0"},"reference-count":123,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Central Statistics Office","award":["This research is part of a PhD funded through the Refund of Fees scheme from the Irish Central Statistics Office (CSO)."],"award-info":[{"award-number":["This research is part of a PhD funded through the Refund of Fees scheme from the Irish Central Statistics Office (CSO)."]}],"id":[{"id":"https:\/\/ror.org\/02x4af624","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/100012921","name":"Royal College of Surgeons in Ireland","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100012921","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Saf"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s40264-026-01664-8","type":"journal-article","created":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T18:06:57Z","timestamp":1775066817000},"page":"899-920","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Estimating the Prevalence of Prescribed Medication Use in Pregnancy with a Systematic Review and Meta-analysis"],"prefix":"10.1007","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3831-2726","authenticated-orcid":false,"given":"Clare","family":"Sullivan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aisling","family":"Kerr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Cahill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela C.","family":"Flynn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fergal","family":"O\u2019Shaughnessy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Cleary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,1]]},"reference":[{"key":"1664_CR1","first-page":"783","volume":"116","author":"K Dathe","year":"2019","unstructured":"Dathe K, Schaefer C. The use of medication in pregnancy. Dtsch Arztebl Int. 2019;116:783\u201390.","journal-title":"Dtsch Arztebl Int"},{"key":"1664_CR2","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1136\/bmj.322.7281.266","volume":"322","author":"GL Nielsen","year":"2001","unstructured":"Nielsen GL, Sorensen HT, Larsen H, Pedersen L. Risk of adverse birth outcome and miscarriage in pregnant users of non-steroidal anti-inflammatory drugs: population based observational study and case\u2013control study. BMJ. 2001;322:266\u201370.","journal-title":"BMJ"},{"key":"1664_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2024.109724","volume":"153","author":"FJE Vajda","year":"2024","unstructured":"Vajda FJE, O\u2019Brien TJ, Graham JE, Hitchcock AE, Perucca P, Lander CM, et al. Pregnancy, antiseizure medications and unexplained intrauterine foetal death. Epilepsy Behav. 2024;153:109724.","journal-title":"Epilepsy Behav"},{"key":"1664_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4172\/2167-0897.1000135","volume":"3","author":"S Murki","year":"2014","unstructured":"Murki S, Sharma D. Intrauterine growth retardation\u2014a review article. J Neonatal Biol. 2014;3:1\u201311.","journal-title":"J Neonatal Biol"},{"key":"1664_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.reprotox.2024.108561","volume":"125","author":"X Chen","year":"2024","unstructured":"Chen X, Yang Y, Chen L, Wang K. Pregnancy outcomes and birth defects in offspring following non-steroidal anti-inflammatory drugs exposure during pregnancy: a systematic review and meta-analysis. Reprod Toxicol. 2024;125:108561.","journal-title":"Reprod Toxicol"},{"key":"1664_CR6","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.ejogrb.2004.04.022","volume":"117","author":"M De Santis","year":"2004","unstructured":"De Santis M, Straface G, Carducci B, Cavaliere AF, De Santis L, Lucchese A, et al. Risk of drug-induced congenital defects. Eur J Obstet Gynecol Reprod Biol. 2004;117:10\u20139.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"1664_CR7","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000209279","volume":"102","author":"AM Pack","year":"2024","unstructured":"Pack AM, Oskoui M, Williams Roberson S, Donley DK, French J, Gerard EE, et al. Teratogenesis, perinatal, and neurodevelopmental outcomes after in utero exposure to antiseizure medication: practice guideline from the AAN, AES, and SMFM. Neurology. 2024;102:e209279.","journal-title":"Neurology"},{"key":"1664_CR8","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1186\/s12884-025-07771-1","volume":"25","author":"L Kent","year":"2025","unstructured":"Kent L, Lee SI, Singh M, Wambua S, Phillips K, Agrawal U, et al. Prevalence and patterns of pre-existing multimorbidity in pregnancy in Northern Ireland: a population-based, retrospective study using linked routinely collected healthcare data. BMC Pregnancy Childbirth. 2025;25:666.","journal-title":"BMC Pregnancy Childbirth"},{"key":"1664_CR9","doi-asserted-by":"publisher","first-page":"S129","DOI":"10.1007\/s10995-006-0102-2","volume":"10","author":"JD Cragan","year":"2006","unstructured":"Cragan JD, Friedman JM, Holmes LB, Uhl K, Green NS, Riley L. Ensuring the safe and effective use of medications during pregnancy: planning and prevention through preconception care. Matern Child Health J. 2006;10:S129\u201335.","journal-title":"Matern Child Health J"},{"key":"1664_CR10","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/BF00315569","volume":"38","author":"M Bonati","year":"1990","unstructured":"Bonati M, Bortolus R, Marchetti F, Romero M, Tognoni G. Drug use in pregnancy: an overview of epidemiological (drug utilization) studies. Eur J Clin Pharmacol. 1990;38:325\u20138.","journal-title":"Eur J Clin Pharmacol"},{"key":"1664_CR11","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1002\/pds.2184","volume":"20","author":"JR Daw","year":"2011","unstructured":"Daw JR, Hanley GE, Greyson DL, Morgan SG. Prescription drug use during pregnancy in developed countries: a systematic review. Pharmacoepidemiol Drug Saf. 2011;20:895\u2013902.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"1664_CR12","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2022-067585","volume":"13","author":"A Anand","year":"2023","unstructured":"Anand A, Phillips K, Subramanian A, Lee SI, Wang Z, McCowan R, et al. Prevalence of polypharmacy in pregnancy: a systematic review. BMJ Open. 2023;13:e067585.","journal-title":"BMJ Open"},{"key":"1664_CR13","doi-asserted-by":"publisher","DOI":"10.1177\/2050312120935471","volume":"8","author":"Y Ayele","year":"2020","unstructured":"Ayele Y, Mekuria AN, Tola A, Mishore KM, Geleto FB. Prescription drugs use during pregnancy in Ethiopia: a systematic review and meta-analysis. SAGE Open Med. 2020;8:2050312120935471.","journal-title":"SAGE Open Med"},{"key":"1664_CR14","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1002\/pds.3613","volume":"23","author":"RA Charlton","year":"2014","unstructured":"Charlton RA, Neville AJ, Jordan S, Pierini A, Damase-Michel C, Klungsoyr K, et al. Healthcare databases in Europe for studying medicine use and safety during pregnancy. Pharmacoepidemiol Drug Saf. 2014;23:586\u201394.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"1664_CR15","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1093\/ije\/dyaa252","volume":"50","author":"AM Neophytou","year":"2021","unstructured":"Neophytou AM, Kioumourtzoglou MA, Goin DE, Darwin KC, Casey JA. Educational note: addressing special cases of bias that frequently occur in perinatal epidemiology. Int J Epidemiol. 2021;50:337\u201345.","journal-title":"Int J Epidemiol"},{"key":"1664_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s13643-018-0699-4","volume":"7","author":"MJ Page","year":"2018","unstructured":"Page MJ, Shamseer L, Tricco AC. Registration of systematic reviews in PROSPERO: 30,000 records and counting. Syst Rev. 2018;7:32.","journal-title":"Syst Rev"},{"key":"1664_CR17","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.jclinepi.2016.01.021","volume":"75","author":"J McGowan","year":"2016","unstructured":"McGowan J, Sampson M, Salzwedel DM, Cogo E, Foerster V, Lefebvre C. PRESS peer review of electronic search strategies: 2015 guideline statement. J Clin Epidemiol. 2016;75:40\u20136.","journal-title":"J Clin Epidemiol"},{"key":"1664_CR18","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1097\/XEB.0000000000000054","volume":"13","author":"Z Munn","year":"2015","unstructured":"Munn Z, Moola S, Lisy K, Riitano D, Tufanaru C. Methodological guidance for systematic reviews of observational epidemiological studies reporting prevalence and cumulative incidence data. Int J Evid Based Healthc. 2015;13:147\u201353.","journal-title":"Int J Evid Based Healthc"},{"key":"1664_CR19","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1002\/jrsm.1374","volume":"10","author":"MJ Westgate","year":"2019","unstructured":"Westgate MJ. Revtools: an R package to support article screening for evidence synthesis. Res Synth Methods. 2019;10:606\u201314.","journal-title":"Res Synth Methods"},{"key":"1664_CR20","unstructured":"R Core Team. R: a language and environment for statistical computing. R Foundation for Statistical Computing. R version 4.1.3 (2022-03-10) ed. Vienna, Austria: R Foundation for Statistical Computing; 2021."},{"key":"1664_CR21","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1002\/jrsm.13","volume":"1","author":"TV Pereira","year":"2010","unstructured":"Pereira TV, Patsopoulos NA, Salanti G, Ioannidis JP. Critical interpretation of Cochran\u2019s Q test depends on power and prior assumptions about heterogeneity. Res Synth Methods. 2010;1:149\u201361.","journal-title":"Res Synth Methods"},{"key":"1664_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v036.i03","volume":"36","author":"W Viechtbauer","year":"2010","unstructured":"Viechtbauer W. Conducting meta-analyses in R with the metafor package. J Stat Softw. 2010;36:1\u201348.","journal-title":"J Stat Softw"},{"key":"1664_CR23","doi-asserted-by":"publisher","first-page":"108","DOI":"10.3109\/13625187.2013.879568","volume":"19","author":"M Baraka","year":"2014","unstructured":"Baraka M, Steurbaut S, Coomans D, Dupont AG. Determinants of medication use in a multi-ethnic population of pregnant women: a cross-sectional study. Eur J Contracept Reprod Health Care. 2014;19:108\u201320.","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"1664_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.699062","volume":"12","author":"V Belleudi","year":"2021","unstructured":"Belleudi V, Fortinguerra F, Poggi FR, Perna S, Bortolus R, Donati S, et al. The Italian Network for Monitoring Medication Use During Pregnancy (MoM-Net): experience and perspectives. Front Pharmacol. 2021;12:699062.","journal-title":"Front Pharmacol"},{"key":"1664_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph19074186","author":"P D'Aloja","year":"2022","unstructured":"D\u2019Aloja P, Da Cas R, Belleudi V, Fortinguerra F, Poggi FR, Perna S, et al. Drug prescriptions among Italian and immigrant pregnant women resident in Italy: a cross-sectional population-based study. Int J Environ Res Public Health. 2022. https:\/\/doi.org\/10.3390\/ijerph19074186.","journal-title":"Int J Environ Res Public Health"},{"key":"1664_CR26","first-page":"249","volume":"57","author":"F Fortinguerra","year":"2021","unstructured":"Fortinguerra F, Belleudi V, Poggi FR, Bortolus R, Puccini A, Solfrini V, et al. Medication prescriptions before, during and after pregnancy in Italy: a population-based study. Ann Ist Super Sanita. 2021;57:249\u201358.","journal-title":"Ann Ist Super Sanita"},{"key":"1664_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph17113830","author":"A Lupattelli","year":"2020","unstructured":"Lupattelli A, Picinardi M, Cantarutti A, Nordeng H. Use and intentional avoidance of prescribed medications in pregnancy: a cross-sectional, web-based study among 926 women in Italy. Int J Environ Res Public Health. 2020. https:\/\/doi.org\/10.3390\/ijerph17113830.","journal-title":"Int J Environ Res Public Health"},{"key":"1664_CR28","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1007\/s11096-013-9750-7","volume":"35","author":"M Odalovic","year":"2013","unstructured":"Odalovic M, Vezmar Kovacevic S, Nordeng H, Ilic K, Sabo A, Tasic L. Predictors of the use of medications before and during pregnancy. Int J Clin Pharm. 2013;35:408\u201316.","journal-title":"Int J Clin Pharm"},{"key":"1664_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s12884-019-2622-y","volume":"19","author":"J Zhang","year":"2019","unstructured":"Zhang J, Ung COL, Guan X, Shi L. Safety of medication use during pregnancy in mainland China: based on a national health insurance database in 2015. BMC Pregnancy Childbirth. 2019;19:459.","journal-title":"BMC Pregnancy Childbirth"},{"key":"1664_CR30","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1007\/s10995-014-1611-z","volume":"19","author":"SC Tinker","year":"2015","unstructured":"Tinker SC, Broussard CS, Frey MT, Gilboa SM. Prevalence of prescription medication use among non-pregnant women of childbearing age and pregnant women in the United States: NHANES, 1999\u20132006. Matern Child Health J. 2015;19:1097\u2013106.","journal-title":"Matern Child Health J"},{"key":"1664_CR31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0067405","volume":"8","author":"K Palmsten","year":"2013","unstructured":"Palmsten K, Huybrechts KF, Mogun H, Kowal MK, Williams PL, Michels KB, et al. Harnessing the Medicaid Analytic eXtract (MAX) to evaluate medications in pregnancy: design considerations. PLoS ONE. 2013;8:e67405.","journal-title":"PLoS ONE"},{"key":"1664_CR32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0274355","volume":"17","author":"A Berard","year":"2022","unstructured":"Berard A, Kaul P, Eltonsy S, Winquist B, Chateau D, Hawken S, et al. The Canadian Mother-Child Cohort Active Surveillance Initiative (CAMCCO): Comparisons between Quebec, Manitoba, Saskatchewan, and Alberta. PLoS ONE. 2022;17:e0274355.","journal-title":"PLoS ONE"},{"key":"1664_CR33","doi-asserted-by":"publisher","DOI":"10.1002\/hsr2.70644","volume":"8","author":"M Brian","year":"2025","unstructured":"Brian M, Goruntla N, Bommireddy BR, Mopuri B, Vigneshwaran E, Mantargi MJS, et al. Knowledge, attitude, and practice of medication use during pregnancy: a cross-sectional study in western Uganda. Health Sci Rep. 2025;8:e70644.","journal-title":"Health Sci Rep."},{"key":"1664_CR34","doi-asserted-by":"publisher","first-page":"2755","DOI":"10.2147\/JMDH.S455378","volume":"17","author":"CT de Castro","year":"2024","unstructured":"de Castro CT, Leal LF, Ramos DO, Santana JDM, Cordeiro RC, Rivemales M, et al. Racial disparities in medication use during pregnancy: results from the NISAMI cohort. J Multidiscip Healthc. 2024;17:2755\u201375.","journal-title":"J Multidiscip Healthc"},{"key":"1664_CR35","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.therap.2020.07.002","volume":"76","author":"M Araujo","year":"2021","unstructured":"Araujo M, Hurault-Delarue C, Sommet A, Damase-Michel C, Benevent J, Lacroix I. Drug prescriptions in French pregnant women between 2015 and 2016: a study in the EGB database. Therapie. 2021;76:239\u201347.","journal-title":"Therapie"},{"key":"1664_CR36","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1002\/pds.2159","volume":"20","author":"M Artama","year":"2011","unstructured":"Artama M, Gissler M, Malm H, Ritvanen A, Drugs, Pregnancy Study G. Nationwide register-based surveillance system on drugs and pregnancy in Finland 1996-2006. Pharmacoepidemiol Drug Saf. 2011;20:729\u201338.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"1664_CR37","doi-asserted-by":"publisher","first-page":"900","DOI":"10.3109\/14767058.2013.765843","volume":"26","author":"MA Baraka","year":"2013","unstructured":"Baraka MA, Steurbaut S, Coomans D, Dupont AG. Ethnic differences in drug utilization pattern during pregnancy: a cross-sectional study. J Matern-Fetal Neonatal Med. 2013;26:900\u20137.","journal-title":"J Matern-Fetal Neonatal Med"},{"key":"1664_CR38","doi-asserted-by":"publisher","first-page":"90","DOI":"10.26650\/IstanbulJPharm.2022.980889","volume":"52","author":"BT Bebito\u011flu","year":"2022","unstructured":"Bebito\u011flu BT, H\u0131d\u0131ro\u011flu S, Ayaz R, Sar\u0131salt\u0131k A, Ko\u00e7 D. Investigation of medication use patterns among pregnant women attending a tertiary referral hospital. Istanbul J Pharm. 2022;52:90\u20135.","journal-title":"Istanbul J Pharm"},{"key":"1664_CR39","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0219095","volume":"14","author":"A Berard","year":"2019","unstructured":"Berard A, Abbas-Chorfa F, Kassai B, Vial T, Nguyen KA, Sheehy O, et al. The French pregnancy cohort: medication use during pregnancy in the French population. PLoS ONE. 2019;14:e0219095.","journal-title":"PLoS ONE"},{"key":"1664_CR40","doi-asserted-by":"publisher","DOI":"10.2147\/CLEP.S17747","author":"A-MB Bj\u00f8rn","year":"2011","unstructured":"Bj\u00f8rn A-MB, N\u00f8rgaard M, Hundborg HH, Nohr EA, Ehrenstein V. Use of prescribed drugs among primiparous women: an 11-year population-based study in Denmark. Clin Epidemiol. 2011. https:\/\/doi.org\/10.2147\/CLEP.S17747.","journal-title":"Clin Epidemiol"},{"key":"1664_CR41","volume":"147","author":"C Bornhauser","year":"2017","unstructured":"Bornhauser C, Quack Lotscher K, Seifert B, Simoes-Wust AP. Diet, medication use and drug intake during pregnancy: data from the consecutive Swiss health surveys of 2007 and 2012. Swiss Med Wkly. 2017;147:w14572.","journal-title":"Swiss Med Wkly"},{"key":"1664_CR42","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph19031389","author":"M Ceulemans","year":"2022","unstructured":"Ceulemans M, Foulon V, Panchaud A, Winterfeld U, Pomar L, Lambelet V, et al. Self-reported medication use among pregnant and breastfeeding women during the COVID-19 pandemic: a cross-sectional study in five European countries. Int J Environ Res Public Health. 2022. https:\/\/doi.org\/10.3390\/ijerph19031389.","journal-title":"Int J Environ Res Public Health"},{"key":"1664_CR43","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1002\/pds.4862","volume":"28","author":"M Ceulemans","year":"2019","unstructured":"Ceulemans M, Van Calsteren K, Allegaert K, Foulon V. Health products\u2019 and substance use among pregnant women visiting a tertiary hospital in Belgium: a cross-sectional study. Pharmacoepidemiol Drug Saf. 2019;28:1231\u20138.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"1664_CR44","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1002\/pds.1906","volume":"19","author":"BJ Cleary","year":"2010","unstructured":"Cleary BJ, Butt H, Strawbridge JD, Gallagher PJ, Fahey T, Murphy DJ. Medication use in early pregnancy-prevalence and determinants of use in a prospective cohort of women. Pharmacoepidemiol Drug Saf. 2010;19:408\u201317.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"1664_CR45","doi-asserted-by":"publisher","first-page":"595","DOI":"10.2165\/11589170-000000000-00000","volume":"34","author":"S Crespin","year":"2011","unstructured":"Crespin S, Bourrel R, Hurault-Delarue C, Lapeyre-Mestre M, Montastruc JL, Damase-Michel C. Drug prescribing before and during pregnancy in South West France: a retrolective study. Drug Saf. 2011;34:595\u2013604.","journal-title":"Drug Saf"},{"key":"1664_CR46","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1177\/0890334418775630","volume":"35","author":"M de Waard","year":"2019","unstructured":"de Waard M, Blomjous BS, Hol MLF, Sie SD, Corpeleijn WE, van Goudoever JHB, et al. Medication use during pregnancy and lactation in a Dutch population. J Hum Lact. 2019;35:154\u201364.","journal-title":"J Hum Lact"},{"key":"1664_CR47","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s12884-015-0489-0","volume":"15","author":"P Dillon","year":"2015","unstructured":"Dillon P, O\u2019Brien KK, McDonnell R, Donnelly-Swift E, Galvin R, Roche A, et al. Prevalence of prescribing in pregnancy using the Irish primary care research network: a pilot study. BMC Pregnancy Childbirth. 2015;15:67.","journal-title":"BMC Pregnancy Childbirth"},{"key":"1664_CR48","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1002\/pds.4577","volume":"27","author":"A Engeland","year":"2018","unstructured":"Engeland A, Bjorge T, Klungsoyr K, Hjellvik V, Skurtveit S, Furu K. Trends in prescription drug use during pregnancy and postpartum in Norway, 2005 to 2015. Pharmacoepidemiol Drug Saf. 2018;27:995\u20131004.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"1664_CR49","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0287111","volume":"18","author":"F Fortinguerra","year":"2023","unstructured":"Fortinguerra F, Belleudi V, Poggi FR, Perna S, Bortolus R, Donati S, et al. Monitoring medicine prescriptions before, during and after pregnancy in Italy. PLoS ONE. 2023;18:e0287111.","journal-title":"PLoS ONE"},{"key":"1664_CR50","doi-asserted-by":"crossref","unstructured":"Gerbier E, Favre G, Tauqeer F, Winterfeld U, Stojanov M, Oliver A, et al. Self-reported medication use among pregnant and postpartum women during the third wave of the COVID-19 pandemic: a European multinational cross-sectional study. Int J Environ Res Public Health. 2022;19:1\u201316.","DOI":"10.3390\/ijerph19095335"},{"key":"1664_CR51","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0267710","volume":"17","author":"J Given","year":"2022","unstructured":"Given J, Casson K, Dolk H, Loane M. Sociodemographic variation in prescriptions dispensed in early pregnancy in Northern Ireland 2010\u20132016. PLoS ONE. 2022;17:e0267710.","journal-title":"PLoS ONE"},{"key":"1664_CR52","doi-asserted-by":"publisher","first-page":"2377","DOI":"10.1111\/bcp.14341","volume":"86","author":"E Houben","year":"2020","unstructured":"Houben E, Te Winkel B, Steegers EAP, Herings RMC. Dutch trends in the use of potentially harmful medication during pregnancy. Br J Clin Pharmacol. 2020;86:2377\u201392.","journal-title":"Br J Clin Pharmacol"},{"key":"1664_CR53","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1002\/pds.4355","volume":"27","author":"KG Ingstrup","year":"2018","unstructured":"Ingstrup KG, Liu X, Gasse C, Debost JP, Munk-Olsen T. Prescription drug use in pregnancy and variations according to prior psychiatric history. Pharmacoepidemiol Drug Saf. 2018;27:105\u201313.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"1664_CR54","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1002\/pds.5299","volume":"30","author":"L Larcin","year":"2021","unstructured":"Larcin L, Lona M, Karakaya G, Van Espen A, Damase-Michel C, Kirakoya-Samadoulougou F. Using administrative healthcare database records to study trends in prescribed medication dispensed during pregnancy in Belgium from 2003 to 2017. Pharmacoepidemiol Drug Saf. 2021;30:1224\u201332.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"1664_CR55","doi-asserted-by":"publisher","DOI":"10.1002\/pds.5705","volume":"33","author":"L Larcin","year":"2024","unstructured":"Larcin L, Neven A, Damase-Michel C, Kirakoya-Samadoulougou F. Belgian medication exposure during pregnancy (BeMeP), a new nationwide linked database: linkage methods and prevalence of medication use. Pharmacoepidemiol Drug Saf. 2024;33:e5705.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"1664_CR56","doi-asserted-by":"publisher","first-page":"3616","DOI":"10.57187\/s.3616","volume":"154","author":"CA Marxer","year":"2024","unstructured":"Marxer CA, Graber SM, Surbek D, Panchaud A, Meier CR, Spoendlin J. Dispensed drugs during pregnancy in outpatient care between 2015 and 2021 in Switzerland: a retrospective analysis of Swiss healthcare claims data. Swiss Med Wkly. 2024;154:3616.","journal-title":"Swiss Med Wkly"},{"key":"1664_CR57","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1186\/s12906-017-2052-1","volume":"17","author":"JS McLay","year":"2017","unstructured":"McLay JS, Izzati N, Pallivalapila AR, Shetty A, Pande B, Rore C, et al. Pregnancy, prescription medicines and the potential risk of herb-drug interactions: a cross-sectional survey. BMC Complement Altern Med. 2017;17:543.","journal-title":"BMC Complement Altern Med"},{"key":"1664_CR58","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0198618","volume":"13","author":"M Navaro","year":"2018","unstructured":"Navaro M, Vezzosi L, Santagati G, Angelillo IF, Collaborative Working G. Knowledge, attitudes, and practice regarding medication use in pregnant women in Southern Italy. PLoS ONE. 2018;13:e0198618.","journal-title":"PLoS ONE"},{"key":"1664_CR59","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1007\/s11096-012-9665-8","volume":"34","author":"M Odalovic","year":"2012","unstructured":"Odalovic M, Vezmar Kovacevic S, Ilic K, Sabo A, Tasic L. Drug use before and during pregnancy in Serbia. Int J Clin Pharm. 2012;34:719\u201327.","journal-title":"Int J Clin Pharm"},{"key":"1664_CR60","doi-asserted-by":"publisher","first-page":"43","DOI":"10.2147\/CLEP.S16305","volume":"3","author":"O Stephansson","year":"2011","unstructured":"Stephansson O, Granath F, Svensson T, Haglund B, Ekbom A, Kieler H. Drug use during pregnancy in Sweden - assessed by the Prescribed Drug Register and the Medical Birth Register. Clin Epidemiol. 2011;3:43\u201350.","journal-title":"Clin Epidemiol"},{"key":"1664_CR61","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1111\/aogs.14805","volume":"103","author":"MO Thunbo","year":"2024","unstructured":"Thunbo MO, Vendelbo JH, Witte DR, Larsen A, Pedersen LH. Use of medication in pregnancy on the rise: study on 1.4 million Danish pregnancies from 1998 to 2018. Acta Obstet Gynecol Scand. 2024;103:1210\u201323.","journal-title":"Acta Obstet Gynecol Scand"},{"key":"1664_CR62","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1186\/s12889-018-5545-z","volume":"18","author":"M Ventura","year":"2018","unstructured":"Ventura M, Maraschini A, D\u2019Aloja P, Kirchmayer U, Lega I, Davoli M, et al. Drug prescribing during pregnancy in a central region of Italy, 2008\u20132012. BMC Public Health. 2018;18:623\u2013623.","journal-title":"BMC Public Health"},{"key":"1664_CR63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40264-018-0722-7","volume":"42","author":"S Vorstenbosch","year":"2019","unstructured":"Vorstenbosch S, Te Winkel B, van Gelder M, Kant A, Roeleveld N, van Puijenbroek E. Aim and design of pREGnant, the Dutch pregnancy drug register. Drug Saf. 2019;42:1\u201312.","journal-title":"Drug Saf"},{"key":"1664_CR64","doi-asserted-by":"publisher","first-page":"593","DOI":"10.2165\/11532330-000000000-00000","volume":"33","author":"L Irvine","year":"2010","unstructured":"Irvine L, Flynn RW, Libby G, Crombie IK, Evans JM. Drugs dispensed in primary care during pregnancy: a record-linkage analysis in Tayside, Scotland. Drug Saf. 2010;33:593\u2013604.","journal-title":"Drug Saf"},{"key":"1664_CR65","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1186\/1471-2393-14-325","volume":"14","author":"C Admasie","year":"2014","unstructured":"Admasie C, Wasie B, Abeje G. Determinants of prescribed drug use among pregnant women in Bahir Dar city administration, Northwest Ethiopia: a cross sectional study. BMC Pregnancy Childbirth. 2014;14:325\u2013325.","journal-title":"BMC Pregnancy Childbirth"},{"key":"1664_CR66","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1186\/s12884-020-03327-7","volume":"20","author":"NM Alema","year":"2020","unstructured":"Alema NM, Semagn G, Melesse S, Araya EM, Gebremedhin H, Demsie DG, et al. Patterns and determinants of prescribed drug use among pregnant women in Adigrat general hospital, northern Ethiopia: a cross-sectional study. BMC Pregnancy Childbirth. 2020;20:624\u2013624.","journal-title":"BMC Pregnancy Childbirth"},{"key":"1664_CR67","doi-asserted-by":"publisher","DOI":"10.1155\/2024\/5577862","volume":"2024","author":"MA Alemu","year":"2024","unstructured":"Alemu MA, Zewdu WS, Ferede YA, Zeleke MM, Ayele TM, Assefa AN, et al. Patterns, potential teratogenicity, and associated factors of drugs prescribed to pregnant women attending antenatal care units in Debre Tabor Comprehensive Specialized Hospital, Debre Tabor, Northwest Ethiopia. BioMed Res Int. 2024;2024:5577862.","journal-title":"BioMed Res Int"},{"key":"1664_CR68","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1186\/s13104-018-3966-5","volume":"11","author":"N Bedewi","year":"2018","unstructured":"Bedewi N, Sisay M, Edessa D. Drug utilization pattern among pregnant women attending maternal and child health clinic of tertiary hospital in eastern Ethiopia: consideration of toxicological perspectives. BMC Res Notes. 2018;11:858.","journal-title":"BMC Res Notes"},{"key":"1664_CR69","first-page":"347","volume":"5","author":"K Etefa","year":"2015","unstructured":"Etefa K, Kahissay M. Assessment of drug prescribing pattern among pregnant women attending antenatal care in health centers found in Arada Subcity, Addis Ababa, Ethiopia. J Pharm Sci Biosci Res. 2015;5:347\u201362.","journal-title":"J Pharm Sci Biosci Res."},{"key":"1664_CR70","first-page":"75","volume":"4","author":"GL Gebremedhin","year":"2014","unstructured":"Gebremedhin GL, Gomathi P. Assessment of drug use and effect in pregnant women attending antenatal care in hospitals of Mekelle, Tigray, Ethiopia. J Drug Deliv Ther. 2014;4:75\u201382.","journal-title":"J Drug Deliv Ther."},{"key":"1664_CR71","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1186\/s12884-018-2081-x","volume":"18","author":"AZ Leke","year":"2018","unstructured":"Leke AZ, Dolk H, Loane M, Casson K, Maboh NM, Maeya SE, et al. First trimester medication use in pregnancy in Cameroon: a multi-hospital survey. BMC Pregnancy Childbirth. 2018;18:450.","journal-title":"BMC Pregnancy Childbirth"},{"key":"1664_CR72","first-page":"116","volume":"3","author":"MA Mohammed","year":"2013","unstructured":"Mohammed MA, Ahmed JH, Bushra AW, Aljadhey HS. Medications use among pregnant women in Ethiopia: a cross sectional study. J Appl Pharm Sci. 2013;3:116\u201323.","journal-title":"J Appl Pharm Sci"},{"key":"1664_CR73","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1186\/s12884-017-1359-8","volume":"17","author":"F Molla","year":"2017","unstructured":"Molla F, Assen A, Abrha S, Masresha B, Gashaw A, Wondimu A, et al. Prescription drug use during pregnancy in Southern Tigray region, North Ethiopia. BMC Pregnancy Childbirth. 2017;17:170.","journal-title":"BMC Pregnancy Childbirth"},{"key":"1664_CR74","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1186\/1471-2393-14-322","volume":"14","author":"D Mosha","year":"2014","unstructured":"Mosha D, Mazuguni F, Mrema S, Abdulla S, Genton B. Medication exposure during pregnancy: a pilot pharmacovigilance system using health and demographic surveillance platform. BMC Pregnancy Childbirth. 2014;14:322.","journal-title":"BMC Pregnancy Childbirth"},{"key":"1664_CR75","doi-asserted-by":"publisher","first-page":"78","DOI":"10.4103\/2045-080X.132658","volume":"5","author":"M Negasa","year":"2014","unstructured":"Negasa M, Tigabu BM. Drug prescribing pattern among pregnant mothers attending obstetrics and gynecology department in Hiwot Fana Specialized Teaching Hospital, Ethiopia. Arch Pharm Pract. 2014;5:78\u201383.","journal-title":"Arch Pharm Pract"},{"key":"1664_CR76","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.4314\/ahs.v20i3.24","volume":"20","author":"ST Obadeji","year":"2020","unstructured":"Obadeji ST, Obadeji A, Bamidele JO, Ajayi FT. Medication use among pregnant women at a secondary health institution: utilisation patterns and predictors of quantity. Afr Health Sci. 2020;20:1206\u201316.","journal-title":"Afr Health Sci"},{"key":"1664_CR77","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1186\/s13104-019-4641-1","volume":"12","author":"BK Alemu","year":"2019","unstructured":"Alemu BK, Wolle NN. Prescription drug use and potential teratogenicity risk among pregnant women attending maternal and child health clinic of Kemisse General Hospital, Northeast, Ethiopia. BMC Res Notes. 2019;12:592.","journal-title":"BMC Res Notes"},{"key":"1664_CR78","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0093870","volume":"9","author":"A Berard","year":"2014","unstructured":"Berard A, Sheehy O. The Quebec Pregnancy Cohort\u2014prevalence of medication use during gestation and pregnancy outcomes. PLoS ONE. 2014;9:e93870.","journal-title":"PLoS ONE"},{"key":"1664_CR79","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1111\/j.1523-536X.2010.00408.x","volume":"37","author":"J Bercaw","year":"2010","unstructured":"Bercaw J, Maheshwari B, Sangi-Haghpeykar H. The use during pregnancy of prescription, over-the-counter, and alternative medications among Hispanic women. Birth. 2010;37:211\u20138.","journal-title":"Birth"},{"key":"1664_CR80","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000033828","volume":"102","author":"YC Chang","year":"2023","unstructured":"Chang YC, Huang HY, Shen TH, Wu CH. Prevalence, trends, and characteristics of polypharmacy among US pregnant women aged 15 to 44 years: NHANES 1999 to 2016. Medicine (Baltimore). 2023;102:e33828.","journal-title":"Medicine (Baltimore)"},{"key":"1664_CR81","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.clinthera.2011.11.025","volume":"34","author":"JR Daw","year":"2012","unstructured":"Daw JR, Mintzes B, Law MR, Hanley GE, Morgan SG. Prescription drug use in pregnancy: a retrospective, population-based study in British Columbia, Canada (2001\u20132006). Clin Ther. 2012;34:239-49 e2.","journal-title":"Clin Ther"},{"key":"1664_CR82","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1097\/AOG.0000000000002579","volume":"131","author":"DM Haas","year":"2018","unstructured":"Haas DM, Marsh DJ, Dang DT, Parker CB, Wing DA, Simhan HN, et al. Prescription and other medication use in pregnancy. Obstet Gynecol. 2018;131:789\u201398.","journal-title":"Obstet Gynecol"},{"key":"1664_CR83","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0211319","volume":"14","author":"C Leong","year":"2019","unstructured":"Leong C, Chateau D, Dahl M, Falk J, Katz A, Bugden S, et al. Prescription medication use during pregnancies that resulted in births and abortions (2001\u20132013): a retrospective population-based study in a Canadian population. PLoS ONE. 2019;14:e0211319.","journal-title":"PLoS ONE"},{"key":"1664_CR84","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1097\/AOG.0000000000000982","volume":"126","author":"K Palmsten","year":"2015","unstructured":"Palmsten K, Hernandez-Diaz S, Chambers CD, Mogun H, Lai S, Gilmer TP, et al. The most commonly dispensed prescription medications among pregnant women enrolled in the U.S. Medicaid program. Obstet Gynecol. 2015;126:465\u201373.","journal-title":"Obstet Gynecol"},{"key":"1664_CR85","first-page":"382","volume":"73","author":"EK Roberson","year":"2014","unstructured":"Roberson EK, Hurwitz EL. Prescription drug use during and immediately before pregnancy in Hawai\u2019i\u2014findings from the Hawai\u2019i Pregnancy Risk Assessment Monitoring System, 2009\u20132011. Hawaii J Med Public Health. 2014;73:382\u20136.","journal-title":"Hawaii J Med Public Health"},{"key":"1664_CR86","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0128312","volume":"10","author":"K Smolina","year":"2015","unstructured":"Smolina K, Hanley GE, Mintzes B, Oberlander TF, Morgan S. Trends and determinants of prescription drug use during pregnancy and postpartum in British Columbia, 2002\u20132011: a population-based cohort study. PLoS ONE. 2015;10:e0128312.","journal-title":"PLoS ONE"},{"key":"1664_CR87","doi-asserted-by":"publisher","DOI":"10.3389\/fgwh.2024.1402608","volume":"5","author":"A Almuhareb","year":"2024","unstructured":"Almuhareb A, Al Sharif A, Cahusac P. Knowledge, attitude, and practice of medication use among pregnant women in Riyadh City: a cross-sectional study. Front Glob Womens Health. 2024;5:1402608.","journal-title":"Front Glob Womens Health"},{"key":"1664_CR88","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1007\/s11096-011-9517-y","volume":"33","author":"IM Al-Riyami","year":"2011","unstructured":"Al-Riyami IM, Al-Busaidy IQ, Al-Zakwani IS. Medication use during pregnancy in Omani women. Int J Clin Pharm. 2011;33:634\u201341.","journal-title":"Int J Clin Pharm"},{"key":"1664_CR89","doi-asserted-by":"crossref","unstructured":"Alyami AA, Alem MM, Dorgham SR, Alshamandy SA. Trends of over-the-counter and prescribed medication use during pregnancy: a cross-sectional study. J Multidisc Healthcare. 2023:16:3847\u201356.","DOI":"10.2147\/JMDH.S421087"},{"key":"1664_CR90","doi-asserted-by":"publisher","first-page":"4173","DOI":"10.2147\/JMDH.S440426","volume":"16","author":"RTD Judistiani","year":"2023","unstructured":"Judistiani RTD, Pratiwi AE, Wahyudi K, Gunawan A, Rahmawati A, Ruslami R. Medication use and associated factors among Indonesian pregnant women: a cross-sectional study. J Multidiscip Healthc. 2023;16:4173\u20139.","journal-title":"J Multidiscip Healthc"},{"key":"1664_CR91","first-page":"63.6","volume":"318","author":"JV KHOa","year":"2017","unstructured":"KHOa JV, CHUAab SS, Dallumal RM, Omar SZ. Medications used by pregnant women: any safety concerns? Malay. 2017;318:63.6.","journal-title":"Malay"},{"key":"1664_CR92","doi-asserted-by":"publisher","DOI":"10.3390\/pharmacy5020021","author":"H Nishigori","year":"2017","unstructured":"Nishigori H, Obara T, Nishigori T, Metoki H, Ishikuro M, Mizuno S, et al. Drug use before and during pregnancy in Japan: The Japan Environment and Children\u2019s Study. Pharmacy (Basel). 2017. https:\/\/doi.org\/10.3390\/pharmacy5020021.","journal-title":"Pharmacy (Basel)"},{"key":"1664_CR93","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1007\/s00228-024-03685-7","volume":"80","author":"A Noda","year":"2024","unstructured":"Noda A, Obara T, Shirota M, Ueno F, Matsuzaki F, Hatanaka R, et al. Medication use before and during pregnancy in Japan: the Tohoku Medical Megabank Project Birth and Three-Generation Cohort Study. Eur J Clin Pharmacol. 2024;80:1171\u201380.","journal-title":"Eur J Clin Pharmacol"},{"key":"1664_CR94","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1177\/0976500X221147803","volume":"13","author":"B Rajan","year":"2022","unstructured":"Rajan B, Pasangha E, Devi P, George S. Patterns of medication use and their determinants in pregnancy among women admitted to the obstetrics wards of a tertiary care hospital: a cross-sectional study: patterns of medication use and their determinants in pregnancy. J Pharmacol Pharmacother. 2022;13:388\u201395.","journal-title":"J Pharmacol Pharmacother"},{"key":"1664_CR95","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/s00228-009-0781-x","volume":"66","author":"X Zhu","year":"2010","unstructured":"Zhu X, Qi X, Hao J, Huang Z, Zhang Z, Xing X, et al. Pattern of drug use during the first trimester among Chinese women: data from a population-based cohort study. Eur J Clin Pharmacol. 2010;66:511\u20138.","journal-title":"Eur J Clin Pharmacol"},{"key":"1664_CR96","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.2147\/CLEP.S230589","volume":"11","author":"J Zhang","year":"2019","unstructured":"Zhang J, Ung COL, Wagner AK, Guan X, Shi L. Medication use during pregnancy in Mainland China: a cross-sectional analysis of a national health insurance database. Clin Epidemiol. 2019;11:1057\u201365.","journal-title":"Clin Epidemiol"},{"key":"1664_CR97","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1590\/1806-9304202200040014","volume":"22","author":"HMN Campos","year":"2023","unstructured":"Campos HMN, Mattos MP, Gomes DR. Use of medications by pregnant women in the Family Health Strategy in the Northeast of Brazil. Rev Bras Saude Materno Infant. 2023;22:975\u201386.","journal-title":"Rev Bras Saude Materno Infant"},{"key":"1664_CR98","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph17030989","author":"BH Lutz","year":"2020","unstructured":"Lutz BH, Miranda VIA, Silveira MPT, Dal Pizzol TDS, Mengue SS, da Silveira MF, et al. Medication use among pregnant women from the 2015 Pelotas (Brazil) Birth Cohort Study. Int J Environ Res Public Health. 2020. https:\/\/doi.org\/10.3390\/ijerph17030989.","journal-title":"Int J Environ Res Public Health"},{"key":"1664_CR99","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0234153","volume":"15","author":"S Donald","year":"2020","unstructured":"Donald S, Sharples K, Barson D, Horsburgh S, Parkin L. Patterns of prescription medicine dispensing before and during pregnancy in New Zealand, 2005\u20132015. PLoS ONE. 2020;15:e0234153.","journal-title":"PLoS ONE"},{"key":"1664_CR100","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1111\/1471-0528.17472","volume":"130","author":"H Jackson","year":"2023","unstructured":"Jackson H, Grzeskowiak LE, Enticott J, Callander E. Pharmacoepidemiology and costs of medications dispensed during pregnancy: a retrospective population-based study. BJOG. 2023;130:1317\u201327.","journal-title":"BJOG"},{"key":"1664_CR101","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2013-004365","volume":"4","author":"A Lupattelli","year":"2014","unstructured":"Lupattelli A, Spigset O, Twigg MJ, Zagorodnikova K, Mardby AC, Moretti ME, et al. Medication use in pregnancy: a cross-sectional, multinational web-based study. BMJ Open. 2014;4:e004365.","journal-title":"BMJ Open"},{"key":"1664_CR102","unstructured":"World Health Organization. International classification of diseases eleventh revision (ICD-11). Geneva, Switzerland; 2022."},{"key":"1664_CR103","unstructured":"WHO Collaborating Centre for Drug Statistics Methodology Norwegian Institute of Public Health. Anatomical Therapeutic Chemical (ATC) classification system. Oslo, Norway; 2022."},{"key":"1664_CR104","doi-asserted-by":"publisher","first-page":"2659","DOI":"10.1093\/ajhp\/48.12.2659","volume":"48","author":"MD Sanborn","year":"1991","unstructured":"Sanborn MD, Godwin HN, Pessetto JD. FDA drug classification system. Am J Health Syst Pharm. 1991;48:2659\u201362.","journal-title":"Am J Health Syst Pharm"},{"key":"1664_CR105","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s40264-012-0004-8","volume":"36","author":"MM van Gelder","year":"2013","unstructured":"van Gelder MM, van Rooij IA, de Walle HE, Roeleveld N, Bakker MK. Maternal recall of prescription medication use during pregnancy using a paper-based questionnaire: a validation study in the Netherlands. Drug Saf. 2013;36:43\u201354.","journal-title":"Drug Saf"},{"key":"1664_CR106","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1186\/s12884-015-0745-3","volume":"15","author":"FE Pisa","year":"2015","unstructured":"Pisa FE, Casetta A, Clagnan E, Michelesio E, Vecchi Brumatti L, Barbone F. Medication use during pregnancy, gestational age and date of delivery: agreement between maternal self-reports and health database information in a cohort. BMC Pregnancy Childbirth. 2015;15:310.","journal-title":"BMC Pregnancy Childbirth"},{"key":"1664_CR107","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1111\/j.1471-0528.2009.02377.x","volume":"116","author":"S Kulaga","year":"2009","unstructured":"Kulaga S, Zargarzadeh AH, Berard A. Prescriptions filled during pregnancy for drugs with the potential of fetal harm. BJOG. 2009;116:1788\u201395.","journal-title":"BJOG"},{"key":"1664_CR108","first-page":"9","volume":"17","author":"D Garriguet","year":"2006","unstructured":"Garriguet D. Medication use among pregnant women. Health Rep. 2006;17:9\u201318.","journal-title":"Health Rep"},{"key":"1664_CR109","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/205639","volume":"2013","author":"AR Pallivalappila","year":"2013","unstructured":"Pallivalappila AR, Stewart D, Shetty A, Pande B, McLay JS. Complementary and alternative medicines use during pregnancy: a systematic review of pregnant women and healthcare professional views and experiences. Evid Based Complement Alternat Med. 2013;2013:205639.","journal-title":"Evid Based Complement Alternat Med"},{"key":"1664_CR110","unstructured":"The European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP). Annex 2 to the Guide on Methodological Standards in Pharmacoepidemiology. 2023. https:\/\/encepp.europa.eu\/encepp-toolkit\/methodological-guide_en. Accessed 26 Nov 2025."},{"key":"1664_CR111","unstructured":"The European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (EENCePP). Checklist for Study Protocols (Revision 4) EMA\/540136\/2009. 2018. https:\/\/encepp.europa.eu\/encepp-toolkit\/encepp-checklist-study-protocols_en. Accessed 26 Nov 2025."},{"key":"1664_CR112","unstructured":"European Medicines Agency (EMA). Guideline on good pharmacovigilance practices (GVP) Product- or Population-Specific Considerations III: Pregnant and 5 breastfeeding women EMA\/653036\/2019 Draft for Public Consultation. 2019. https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/draft-guideline-good-pharmacovigilance-practices-product-or-population-specific-considerations-iii-pregnant-breastfeeding-women_en.pdf. Accessed 26 Nov 2025."},{"key":"1664_CR113","unstructured":"U.S. Department of Health and Human Services Food and Drug Administration. Real-World Data: Assessing Electronic Health Records and Medical Claims Data to Support Regulatory Decision-Making for Drug and Biological Products Guidance for Industry. 2024. https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/real-world-data-assessing-electronic-health-records-and-medical-claims-data-support-regulatory. Accessed 26 Nov 2025."},{"key":"1664_CR114","unstructured":"U.S. Department of Health and Human Services Food and Drug Administration. Postapproval Pregnancy Safety Studies Guidance for Industry\u2014Draft Guidance. 2019https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/postapproval-pregnancy-safety-studies-guidance-industry. Accessed 26 Nov 2025."},{"key":"1664_CR115","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/s40264-023-01291-7","volume":"46","author":"JL Richardson","year":"2023","unstructured":"Richardson JL, Moore A, Bromley RL, Stellfeld M, Geissbuhler Y, Bluett-Duncan M, et al. Core Data Elements for pregnancy pharmacovigilance studies using primary source data collection methods: Recommendations from the IMI ConcePTION project. Drug Saf. 2023;46:479\u201391.","journal-title":"Drug Saf"},{"key":"1664_CR116","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s40264-023-01384-3","volume":"47","author":"G Favre","year":"2024","unstructured":"Favre G, Richardson JL, Moore A, Geissbuhler Y, Jehl V, Oliver A, et al. Improving data collection in pregnancy safety studies: towards standardisation of data elements in pregnancy reports from public and private partners, a contribution from the ConcePTION project. Drug Saf. 2024;47:227\u201336.","journal-title":"Drug Saf"},{"key":"1664_CR117","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1002\/cpt.2476","volume":"111","author":"NH Thurin","year":"2022","unstructured":"Thurin NH, Pajouheshnia R, Roberto G, Dodd C, Hyeraci G, Bartolini C, et al. From inception to ConcePTION: Genesis of a network to support better monitoring and communication of medication safety during pregnancy and breastfeeding. Clin Pharmacol Ther. 2022;111:321\u201331.","journal-title":"Clin Pharmacol Ther"},{"key":"1664_CR118","unstructured":"Damase-Michel C, & Wurst, K. Core evidence elements for generating medication safety evidence for pregnancy using population-based data (D1.2). Zenodo; 2021."},{"key":"1664_CR119","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1002\/pds.5353","volume":"31","author":"AV Margulis","year":"2022","unstructured":"Margulis AV, Kawai AT, Anthony MS, Rivero-Ferrer E. Perinatal pharmacoepidemiology: how often are key methodological elements reported in publications? Pharmacoepidemiol Drug Saf. 2022;31:61\u201371.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"1664_CR120","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.k3532","volume":"363","author":"SM Langan","year":"2018","unstructured":"Langan SM, Schmidt SA, Wing K, Ehrenstein V, Nicholls SG, Filion KB, et al. The reporting of studies conducted using observational routinely collected health data statement for pharmacoepidemiology (RECORD-PE). BMJ. 2018;363:k3532.","journal-title":"BMJ"},{"key":"1664_CR121","doi-asserted-by":"publisher","first-page":"e436","DOI":"10.1016\/S2666-7568(21)00115-X","volume":"2","author":"T Diaz","year":"2021","unstructured":"Diaz T, Strong KL, Cao B, Guthold R, Moran AC, Moller AB, et al. A call for standardised age-disaggregated health data. Lancet Healthy Longev. 2021;2:e436\u201343.","journal-title":"Lancet Healthy Longev"},{"key":"1664_CR122","unstructured":"UNESCO Institute for Statistics, International Classification of Education ISCED 2011. 2011. https:\/\/www.oecd.org\/content\/dam\/oecd\/en\/publications\/reports\/2015\/03\/isced-2011-operational-manual_g1g4f697\/9789264228368-en.pdf. Accessed 26 Nov 2025."},{"key":"1664_CR123","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.ejogrb.2021.05.042","volume":"263","author":"H Maraj","year":"2021","unstructured":"Maraj H, Kumari S. No clarity on the definition of parity: a survey accessing interpretation of the word parity amongst obstetricians and midwives and a literature review. Eur J Obstet Gynecol Reprod Biol. 2021;263:15\u20139.","journal-title":"Eur J Obstet Gynecol Reprod Biol"}],"container-title":["Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40264-026-01664-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40264-026-01664-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40264-026-01664-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T05:01:53Z","timestamp":1783659713000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40264-026-01664-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,1]]},"references-count":123,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["1664"],"URL":"https:\/\/doi.org\/10.1007\/s40264-026-01664-8","relation":{},"ISSN":["0114-5916","1179-1942"],"issn-type":[{"value":"0114-5916","type":"print"},{"value":"1179-1942","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,1]]},"assertion":[{"value":"21 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original article has been corrected. Author affiliation numbers are corrected in the author group.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"K.B. has received funding for other projects from IQVIA and Novartis, but those projects are unrelated to this study. The authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"This systematic review summarized information in already published literature, and ethical clearance was not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"Not applicable","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Data sharing is not applicable to this article as no datasets were generated or analyzed during the current study.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}},{"value":"Available in Appendix C and E.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"C.S. coordinated study design, systematic review planning, data extraction, analysis, interpretation, and led article screening, selection, data extraction, quality assessment, and manuscript writing. K.B. contributed to study design and planning, article screening, quality assessment, analysis, interpretation, and manuscript revisions. B.C. and F.O.S. contributed to study design and planning, analysis, interpretation, and manuscript revisions. A.K., M.C., and A.F. contributed to article screening, data extraction, and quality assessment. All authors have read and approved the final version.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 contributions"}}]}}